{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T22:42:18Z","timestamp":1788388938223,"version":"build-2803163510"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"National Key R&D Program of China","award":["2016YFC1303503"],"award-info":[{"award-number":["2016YFC1303503"]}]},{"name":"Key Biochemical Program of Shanghai","award":["17431902200"],"award-info":[{"award-number":["17431902200"]}]},{"name":"Key Biochemical Program of Shanghai","award":["18431902600"],"award-info":[{"award-number":["18431902600"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1016\/j.ejmech.2018.10.017","type":"journal-article","created":{"date-parts":[[2018,10,10]],"date-time":"2018-10-10T18:02:06Z","timestamp":1539194526000},"page":"133-145","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":38,"special_numbering":"C","title":["Tryptophan 2,3-dioxygenase inhibitory activities of tryptanthrin derivatives"],"prefix":"10.1016","volume":"160","author":[{"given":"Shengnan","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fangfei","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hairong","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunxiang","family":"Kuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2018.10.017_bib1","doi-asserted-by":"crossref","first-page":"938","DOI":"10.2174\/156800909790192374","article-title":"Indoleamine 2,3-Dioxygenase, an emerging target for anti-cancer therapy","volume":"9","author":"Liu","year":"2009","journal-title":"Curr. Cancer Drug Targets"},{"key":"10.1016\/j.ejmech.2018.10.017_bib2","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1007\/s00726-010-0787-9","article-title":"Kynurenine metabolism in health and disease","volume":"41","author":"Kolodziej","year":"2011","journal-title":"Amino Acids"},{"key":"10.1016\/j.ejmech.2018.10.017_bib3","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/S0891-5849(99)00272-5","article-title":"Comparative effects of oxygen on indoleamine 2,3-dioxygenase and trypto- phan 2,3-dioxygenase of the kynurenine pathway","volume":"28","author":"Dang","year":"2000","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.ejmech.2018.10.017_bib4","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1124\/pr.113.008144","article-title":"Neuroinflammation and comorbidity of pain and depression","volume":"66","author":"Walker","year":"2013","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.ejmech.2018.10.017_bib5","doi-asserted-by":"crossref","first-page":"5649","DOI":"10.1158\/0008-5472.CAN-12-0549","article-title":"The kynurenine pathway in brain tumor pathogenesis","volume":"72","author":"Adams","year":"2012","journal-title":"Cancer Res."},{"key":"10.1016\/j.ejmech.2018.10.017_bib6","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1007\/s11011-016-9824-z","article-title":"TDO as a therapeutic target in brain diseases","volume":"31","author":"Yu","year":"2016","journal-title":"Metab. Brain Dis."},{"key":"10.1016\/j.ejmech.2018.10.017_bib7","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1515\/bchm2.1936.243.6.237","article-title":"The intermediary metabolism of tryptophan. XVIII. The mechanism of formation of kynurenine from tryptophan","volume":"243","author":"Kotake","year":"1936","journal-title":"Z.\u00a0Physiol. Chem."},{"key":"10.1016\/j.ejmech.2018.10.017_bib8","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.gene.2007.04.010","article-title":"Characterization of an indoleamine 2,3-dioxygenase-like protein found in humans and mice","volume":"396","author":"Ball","year":"2007","journal-title":"Gene"},{"key":"10.1016\/j.ejmech.2018.10.017_bib9","doi-asserted-by":"crossref","first-page":"7082","DOI":"10.1158\/0008-5472.CAN-07-1872","article-title":"Novel tryptophan catabolic enzyme Ido2 is the preferred biochemical target of the antitumor indoleamine 2,3-dioxygenase inhibitory compound D-1-methyl-tryptophan","volume":"67","author":"Metz","year":"2007","journal-title":"Cancer Res."},{"key":"10.1016\/j.ejmech.2018.10.017_bib10","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1007\/s00239-007-9049-1","article-title":"Evolution of vertebrate indoleamine 2,3-dioxygenases","volume":"65","author":"Yuasa","year":"2007","journal-title":"J.\u00a0Mol. Evol."},{"key":"10.1016\/j.ejmech.2018.10.017_bib11","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1073\/pnas.0610007104","article-title":"Molecular insights into substrate recognition and catalysis by tryptophan 2,3-dioxygenase","volume":"104","author":"Forouhar","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"key":"10.1016\/j.ejmech.2018.10.017_bib12","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1111\/j.1471-4159.1993.tb03269.x","article-title":"Identification of tryptophan 2,3-dioxygenase RNA in rodent brain","volume":"60","author":"Haber","year":"1993","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.ejmech.2018.10.017_bib13","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/S0021-9258(19)50967-X","article-title":"The conversion of tryptophan to kynurenine in liver. I. The coupled tryptophan peroxidase-oxidase system forming formylkynurenine","volume":"187","author":"Knox","year":"1950","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ejmech.2018.10.017_bib14","doi-asserted-by":"crossref","first-page":"10910","DOI":"10.1021\/bi201439m","article-title":"Molecular basis for the substrate stereoselectivity in tryptophan dioxygenase","volume":"50","author":"Capece","year":"2011","journal-title":"Biochemistry"},{"key":"10.1016\/j.ejmech.2018.10.017_bib15","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.2174\/0929867033457179","article-title":"Interferon-\u03b3-induced conversion of tryptophan: immunologic and neuropsychiatric aspects","volume":"10","author":"Wirleitner","year":"2003","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.10.017_bib16","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1016\/j.biocel.2007.01.004","article-title":"Molecules in focus: indoleamine 2,3-dioxygenase","volume":"39","author":"King","year":"2007","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.ejmech.2018.10.017_bib17","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.ejmech.2016.07.013","article-title":"Establishment of a human indoleamine 2, 3-dioxygenase 2 (hIDO2) bioassay system and discovery of tryptanthrin derivatives as potent hIDO2 inhibitors","volume":"123","author":"Li","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.10.017_bib18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/1178646917691938","article-title":"Kynurenine pathway of tryptophan metabolism: regulatory and functional aspects","volume":"10","author":"Badawy","year":"2017","journal-title":"Int. J. Tryptophan Res."},{"key":"10.1016\/j.ejmech.2018.10.017_bib19","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1126\/science.281.5380.1191","article-title":"Prevention of allogeneic fetal rejection by tryptophan catabolism","volume":"281","author":"Munn","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.ejmech.2018.10.017_bib20","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1038\/83183","article-title":"Prevention of T cell-driven complement activation and inflammation by tryptophan catabolism during pregnancy","volume":"2","author":"Mellor","year":"2001","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.ejmech.2018.10.017_bib21","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.jri.2003.11.002","article-title":"Indoleamine2,3-dioxygenase (IDO) expression in invasive extravillous trophoblast supports role of the enzyme for maternal-fetal tolerance","volume":"61","author":"H\u00f6nig","year":"2004","journal-title":"J.\u00a0Reprod. Immunol."},{"key":"10.1016\/j.ejmech.2018.10.017_bib22","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1158\/1535-7163.MCT-09-0628","article-title":"Hydroxyamidine inhibitors of indoleamine-2,3-dioxygenase potently suppress systemic tryptophan catabolism and the growth of Ido-Expressing tumors","volume":"9","author":"Koblish","year":"2010","journal-title":"Mol. Canc. Therapeut."},{"key":"10.1016\/j.ejmech.2018.10.017_bib23","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1016\/j.jaci.2015.10.033","article-title":"The mannose receptor negatively modulates the Toll-like receptor 4-aryl hydrocarbon receptor-indoleamine 2,3-dioxygenase axis in dendritic cells affecting T helper cell polarization","volume":"137","author":"Salazar","year":"2016","journal-title":"J.\u00a0Allergy Clin. Immunol."},{"key":"10.1016\/j.ejmech.2018.10.017_bib24","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1093\/brain\/115.5.1249","article-title":"Quinolinic acid and kynurenine pathway metabolism in inflammatory and non-inflammatory neurological disease","volume":"115","author":"Heyes","year":"1992","journal-title":"Brain"},{"key":"10.1016\/j.ejmech.2018.10.017_bib25","doi-asserted-by":"crossref","first-page":"9992","DOI":"10.1039\/C7OB02529G","article-title":"Discovery of IDO1 and DNA dual targeting antitumor agents","volume":"15","author":"Fang","year":"2017","journal-title":"Org. Biomol. Chem."},{"key":"10.1016\/j.ejmech.2018.10.017_bib26","doi-asserted-by":"crossref","first-page":"2755","DOI":"10.1002\/eji.200939535","article-title":"Antimicrobial and immunoregulatory properties of human tryptophan 2,3-dioxygenase","volume":"39","author":"Schmidt","year":"2009","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.ejmech.2018.10.017_bib27","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1073\/pnas.1113873109","article-title":"Reversal of tumoral immune resistance by inhibition of tryptophan 2,3-dioxygenase","volume":"109","author":"Pilotte","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"key":"10.1016\/j.ejmech.2018.10.017_bib28","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/nature10491","article-title":"An endogenous tumor-promoting ligand of the human aryl hydrocarbon receptor","volume":"478","author":"Opitz","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2018.10.017_bib29","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1017\/S1461145713001673","article-title":"Inhibition of stress-induced hepatic tryptophan 2,3-dioxygenase exhibits antidepressant activity in an animal model of depressive behavior","volume":"17","author":"Gibney","year":"2014","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.ejmech.2018.10.017_bib30","doi-asserted-by":"crossref","first-page":"14912","DOI":"10.1073\/pnas.1203083109","article-title":"Delaying aging and the aging-associated decline in protein homeostasis by inhibition of tryptophan degradation","volume":"109","author":"van der Goot","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"key":"10.1016\/j.ejmech.2018.10.017_bib31","doi-asserted-by":"crossref","first-page":"41271","DOI":"10.1038\/srep41271","article-title":"Tryptophan-2,3-Dioxygenase (TDO) deficiency is associated with subclinical neuroprotection in a mouse model of multiple sclerosis","volume":"24","author":"Lanz","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejmech.2018.10.017_bib32","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1016\/0006-2952(95)00006-L","article-title":"The effects of a novel and selective inhibitor of tryptophan 2,3-dioygenase on tryptophan and serotonin metabolism in the rat","volume":"49","author":"Salter","year":"1995","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejmech.2018.10.017_bib33","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.bbrc.2013.11.037","article-title":"Antitumor agents as inhibitors of tryptophan 2,3-dioxygenase","volume":"443","author":"Pantouris","year":"2014","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ejmech.2018.10.017_bib34","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1177\/1087057114536616","article-title":"High-throughput fluorescence-based screening assays for tryptophan catabolizing enzymes","volume":"19","author":"Seegers","year":"2014","journal-title":"J.\u00a0Biomol. Screen"},{"key":"10.1016\/j.ejmech.2018.10.017_bib35","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/j.ibmb.2008.05.011","article-title":"Purification and biochemical characterization of a recombinant Anopheles gambiae tryptophan 2,3-dioxygenase expressed in Escherichia coli","volume":"38","author":"Paglino","year":"2008","journal-title":"Insect. Biochem. Mol. Biol."},{"key":"10.1016\/j.ejmech.2018.10.017_bib36","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.ab.2005.10.039","article-title":"A\u00a0fluorescence-based assay for indoleamine 2,3-dioxygenase","volume":"349","author":"Matin","year":"2006","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.ejmech.2018.10.017_bib37","doi-asserted-by":"crossref","first-page":"7807","DOI":"10.1021\/acs.jmedchem.5b00921","article-title":"Identification of substituted naphthotriazolediones as novel tryptophan 2,3-dioxygenase (TDO) inhibitors through structure-based virtual screening","volume":"58","author":"Wu","year":"2015","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2018.10.017_bib38","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1021\/acsmedchemlett.6b00458","article-title":"Targeting the inhibition of tryptophan 2,3-dioxygenase (TDO-2) for cancer treatment","volume":"8","author":"Abdel-Magid","year":"2016","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2018.10.017_bib39","first-page":"P196","article-title":"Preclinical assessment of a novel small molecule inhibitor of tryptophan 2,3-dioxygenase 2 (TDO2)","volume":"2","author":"Crosignani","year":"2014","journal-title":"J.\u00a0Immuno. Ther. Cancer."},{"key":"10.1016\/j.ejmech.2018.10.017_bib40","doi-asserted-by":"crossref","first-page":"3260","DOI":"10.1021\/ja807969a","article-title":"Substrate-protein interaction in human tryptophan dioxygenase: the critical role of H76","volume":"131","author":"Batabyal","year":"2009","journal-title":"J.\u00a0Am. Chem. Soc."},{"key":"10.1016\/j.ejmech.2018.10.017_bib41","doi-asserted-by":"crossref","first-page":"3210","DOI":"10.1002\/prot.24653","article-title":"Structural and functional analyses of human tryptophan 2,3-dioxygenase","volume":"82","author":"Meng","year":"2014","journal-title":"Proteins"},{"key":"10.1016\/j.ejmech.2018.10.017_bib42","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1093\/jb\/mvp002","article-title":"Cooperative binding of L-Trp to human tryptophan 2,3-dioxygenase: resonance Raman spectroscopic analysis","volume":"145","author":"Fukumura","year":"2009","journal-title":"J.\u00a0Biochem."},{"key":"10.1016\/j.ejmech.2018.10.017_bib43","doi-asserted-by":"crossref","first-page":"15690","DOI":"10.1021\/ja076186k","article-title":"Human tryptophan dioxygenase: a comparison to indoleamine 2,3-dioxygenase","volume":"129","author":"Batabyal","year":"2007","journal-title":"J.\u00a0Am. Chem. Soc."},{"key":"10.1016\/j.ejmech.2018.10.017_bib44","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1021\/acsmedchemlett.6b00391","article-title":"INCB24360 (Epacadostat), a highly potent and selective indoleamine-2,3-dioxygenase 1 (IDO1) inhibitor for immuno-oncology","volume":"8","author":"Yue","year":"2017","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2018.10.017_bib45","doi-asserted-by":"crossref","first-page":"4186","DOI":"10.1021\/ja808326g","article-title":"Reassessment of the reaction mechanism in the heme dioxygenases","volume":"131","author":"Chauhan","year":"2009","journal-title":"J.\u00a0Am. Chem. Soc."},{"key":"10.1016\/j.ejmech.2018.10.017_bib46","doi-asserted-by":"crossref","first-page":"8321","DOI":"10.1021\/jm401195n","article-title":"Discovery of tryptanthrin derivatives as potent inhibitors of indoleamine 2,3-Dioxygenase with therapeutic activity in Lewis lung Cancer (LLC) tumor-bearing mice","volume":"56","author":"Yang","year":"2013","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2018.10.017_bib47","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1002\/jcc.20634","article-title":"A\u00a0semiempirical free energy force field with charge-based desolvation","volume":"28","author":"Huey","year":"2007","journal-title":"J.\u00a0Comput. Chem."},{"key":"10.1016\/j.ejmech.2018.10.017_bib48","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1002\/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B","article-title":"Automated docking using a Lamarckian genetic algorithm and an empirical binding free energy function","volume":"19","author":"Morris","year":"1998","journal-title":"J.\u00a0Comput. Chem."},{"key":"10.1016\/j.ejmech.2018.10.017_bib49","doi-asserted-by":"crossref","first-page":"5680","DOI":"10.1016\/j.ejmech.2011.08.044","article-title":"Structure-activity relationship and enzyme kinetic studies on 4-aryl-1H-1,2,3-triazoles as indoleamine 2,3-dioxygenase (IDO) inhibitors","volume":"46","author":"Huang","year":"2011","journal-title":"Eur. J. Med. Chem."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523418308791?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523418308791?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,9,3]],"date-time":"2022-09-03T19:21:34Z","timestamp":1662232894000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523418308791"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":49,"alternative-id":["S0223523418308791"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2018.10.017","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tryptophan 2,3-dioxygenase inhibitory activities of tryptanthrin derivatives","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2018.10.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}